Premium
Biochemical Modulation of 5‐Fluorouracil with Murine Interferon‐α/β Against Murine Renal Cell Carcinoma
Author(s) -
Marumo Ken,
Oya Mototsugu,
Murai Masaru
Publication year - 1997
Publication title -
international journal of urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.172
H-Index - 67
eISSN - 1442-2042
pISSN - 0919-8172
DOI - 10.1111/j.1442-2042.1997.tb00164.x
Subject(s) - thymidylate synthase , thymidine kinase , thymidine , medicine , dna synthesis , in vivo , pharmacology , interferon , cell culture , cancer research , cytosol , alpha interferon , kidney , fluorouracil , microbiology and biotechnology , endocrinology , biology , biochemistry , enzyme , immunology , in vitro , chemotherapy , virus , genetics , herpes simplex virus
Department of Urology, School of Medicine, Keio University, Tokyo, Japan Background Conventional therapy for renal cell carcinoma using interferon (IFN) has shown limited antitumor action. The purpose of our study was to investigate synergistic antitumor effects of IFN and 5‐fluorouracil (5‐FU), and to elucidate the mechanisms of interaction between the 2 agents in mice. Methods Antitumor effects and biochemical modulation of murine IFN‐α/β and 5‐FU were determined against the murine renal cell carcinoma cell line, Renca, in vivo. The activity of thymidylate synthetase and thymidine kinase was measured using cytosolic extracts of the tumors. Results Combination treatment with IFN‐α/β and 5‐FU produced a significant enhancement of growth inhibition against Renca tumor. Treatment with 5‐FU resulted in a 2.7‐fold increase in the total amount of thymidylate synthetase and an 11.6‐fold increase in the thymidylate synthetase inhibition rate, while the administration of IFN‐α/β did not significantly reduce the 5‐FU‐induced increase in thymidylate synthetase. The administration of IFN‐α/β decreased thymidine kinase activity to 65.5% maximally, compared with that in the control mice or the mice treated with 5‐FU. Conclusions The reduction of thymidine kinase caused by treating the mice with IFN‐α/β changes the utilization of exogenous thymidine for DNA synthesis, and may represent the mechanism of the additive antitumor effect of the 2 agents, through the suppression of the salvage pathway for deoxythymidine monophosphate induction.